Gainers
- Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL) shares rose 44.7% to $0.9902 in pre-market trading after the company reported the U.S. FDA approval of REZLIDHIA (olutasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.
- MEI Pharma, Inc.(NASDAQ:MEIP) shares rose 22.2% to $0.40 in pre-market trading. The company, last month, posted a narrower quarterly loss.
- Ra Medical Systems, Inc.(NYSE:RMED) rose 17.7% to $3.73 in pre-market trading after jumping 29% on Thursday. Ra Medical Systems, last month, posted a Q3 loss of $4.36 per share.
- Helbiz, Inc. (NASDAQ:HLBZ) rose 13.3% to $0.2450 in pre-market trading...
Login or create a forever free account to read this news
Sign up/Log in